Clinical Trial Update: Safety and Efficacy of Treg Cell in the Treatment of GVHD [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and efficacy of regulatory T cell therapy for graft-versus-host disease, currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Treg cell therapy

Snippet

Sponsor: Xuzhou Medical University | Conditions: GVHD | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING